Prevalence and Incidence of Neuromyelitis Optica Spectrum Disorder in Korea: Population Based Study

다국어 초록 (Multilingual Abstract)

Background: Although neuromyelitis optica spectrum disorder (NMOSD) is known to be a rare disease, its prevalence and incidence have not yet been studied in Korea. We performed a population-based study to examine the prevalence and incidence of NMOSD in Korea using data from the Korean National Health Insurance (NHI) claims database.
Methods: Data from 2013 to 2017 were obtained, with a washout period set as 2013 and 2014.
The prevalence and incidence of NMOSD in 2016 and 2017 were calculated using population census data. Subjects were divided into 5 groups at 15-year intervals, depending on the age at which the diagnostic code was entered. The relative risk (RR) for each age group was compared with the oldest (≥ 60 years) age group.
Results: The overall prevalence was estimated to be 3.36 and 3.56 per 100,000 individuals, with an incidence of 0.41 and 0.65 per 100,000 individuals-year in 2016 and 2017, respectively. The mean age was 43.08 (standard deviation, 14.56) years, and the ratio of male to females was 1:4.7. The incidence was higher in female individuals aged between 30 and 59 years (RR, 2.8–3.05; P < 0.05).
Conclusion: Nationwide prevalence of NMOSD in Korea was 3.36 and 3.56/100,000 and its incidence was 0.41 and 0.65/100,000-year in 2016 and 2017 respectively.

참고문헌 (Reference)

1 Cossburn M, "The prevalence of neuromyelitis optica in South East Wales" 19 (19): 655-659, 2012

2 Miyamoto K, "The prevalence and characteristics of neuromyelitis optica in Japan : a nationwide epidemiological study" 381 : 787-, 2017

3 Marrie RA, "The incidence and prevalence of neuromyelitis optica : a systematic review" 15 (15): 113-118, 2013

4 Jacob A, "The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom" 260 (260): 2134-2137, 2013

5 Kim SH, "Racial differences in neuromyelitis optica spectrum disorder" 91 (91): e2089-e2099, 2018

6 Hor JY, "Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence" 19 : 20-24, 2018

7 Kim NH, "Prevalence of multiple sclerosis in Korea" 75 (75): 1432-1438, 2010

8 Kim JE, "Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea" 2019

9 Houzen H, "Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan" 89 (89): 1995-2001, 2017

10 Kitley J, "Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies : a comparative study" 71 (71): 276-283, 2014

11 Ashtari F, "Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran : a cross-sectional study" 22 : 41-, 2017

12 Cabre P, "MS and neuromyelitis optica in Martinique(French West Indies)" 56 (56): 507-514, 2001

13 Wingerchuk DM, "International consensus diagnostic criteria for neuromyelitis optica spectrum disorders" 85 (85): 177-189, 2015

14 Langer-Gould A, "Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children" 77 (77): 1143-1148, 2011

15 Bukhari W, "Incidence and prevalence of NMOSD in Australia and New Zealand" 88 (88): 632-638, 2017

16 Kim SM, "Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G" 23 (23): 1104-1111, 2017

17 Mealy MA, "Epidemiology of neuromyelitis optica in the United States : a multicenter analysis" 69 (69): 1176-1180, 2012

18 Flanagan EP, "Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum" 79 (79): 775-783, 2016

19 Asgari N, "Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO)" 60 (60): B4730-, 2013

20 Cabre P, "Environmental changes and epidemiology of multiple sclerosis in the French West Indies" 286 (286): 58-61, 2009

21 Pandit L, "Demographic and clinical features of neuromyelitis optica : a review" 21 (21): 845-853, 2015

22 Chen H, "Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder" 24 (24): 219-226, 2017

23 Etemadifar M, "An epidemiological study of neuromyelitis optica in Isfahan" 20 (20): 1920-1922, 2014

24 Cabrera-Gómez JA, "An epidemiological study of neuromyelitis optica in Cuba" 256 (256): 35-44, 2009

25 Park CY, "Age at natural menopause in Koreans : secular trends and influences thereon" 25 (25): 423-429, 2018

26 Cho GJ, "Age at menarche in a Korean population : secular trends and influencing factors" 169 (169): 89-94, 2010

27 Lee MH, "Age at menarche in Korean adolescents : trends and influencing factors" 13 (13): 121-, 2016